title: Down-regulated c-myb expression inhibits DNA synthesis of T-leukemia cells in most patients.
abstract: We have investigated the functional relevance of c-myb expression for DNA synthesis in patients' T-leukemia cells. [3H]Thymidine incorporation assays of 32 patients' leukemia cells exposed in vitro to c-myb sense or antisense oligodeoxynucleotides served to define two groups of patients: a responder group whose leukemia cells showed 2- to 16-fold lower levels of [3H]thymidine incorporation in c-myb antisense-treated cultures than in c-myb sense-treated cultures (20 patients) and a nonresponder group whose cells showed comparable [3H]thymidine incorporation levels in either c-myb sense- or antisense-treated cultures (12 patients). Down-regulation of c-myb mRNA levels in cells exposed to c-myb antisense oligodeoxynucleotides was comparable in both groups of patients, indicating that differential sensitivity to c-myb antisense oligodeoxynucleotides was not due to differential uptake of these oligodeoxynucleotides. DNA polymerase alpha mRNA levels were down-regulated in cells from the responders but were unaffected in the nonresponder group. These results suggest that c-myb is required for DNA synthesis in cells of many but not all T-leukemia patients and that leukemia cells in which DNA synthesis is not inhibited despite down-regulation of c-myb expression may have undergone some genetic change(s) that obviate(s) the requirement for myb protein.
authors.affiliation: Department of Pathology, Temple University, Philadelphia, Pennsylvania.
authors.forename: D
authors.initials: D
authors.lastname: Venturelli
authors.forename: M T
authors.initials: MT
authors.lastname: Mariano
authors.forename: C
authors.initials: C
authors.lastname: Szczylik
authors.forename: M
authors.initials: M
authors.lastname: Valtieri
authors.forename: B
authors.initials: B
authors.lastname: Lange
authors.forename: W
authors.initials: W
authors.lastname: Crist
authors.forename: M
authors.initials: M
authors.lastname: Link
authors.forename: B
authors.initials: B
authors.lastname: Calabretta
mesh_terms: D001483:Base Sequence; D015152:Blotting, Northern; D004257:DNA Polymerase II / Q000235:genetics; D016373:DNA, Antisense / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D015870:Gene Expression; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000235:genetics / Q000473:pathology*; D008969:Molecular Sequence Data; D009838:Oligodeoxyribonucleotides / Q000494:pharmacology; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D020598:Proto-Oncogene Proteins c-myb; D012333:RNA, Messenger / Q000235:genetics; D012334:RNA, Neoplasm / Q000235:genetics; D001613:beta 2-Microglobulin / Q000235:genetics
chemical_list: D016373:DNA, Antisense; D004273:DNA, Neoplasm; D009838:Oligodeoxyribonucleotides; D011518:Proto-Oncogene Proteins; D020598:Proto-Oncogene Proteins c-myb; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D001613:beta 2-Microglobulin; D004257:DNA Polymerase II